Coherus Biosciences reported $-50443000 in EBITDA for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US USD -45574000 15.21M
Akebia Therapeutics AKBA:US USD 3.88M 42.45M
ALKERMES ALKS:US USD 448K 41.49M
Alnylam Pharmaceuticals ALNY:US USD -174303000 73.14M
Amarin AMRN:US USD 2.2M 39.04M
Amgen AMGN:US USD 3.04B 460M
Baxter International BAX:US USD 646M 209M
Biogen BIIB:US USD 998.8M 6M
Biomarin Pharmaceutical BMRN:US USD 53K 22.33M
Bluebird Bio BLUE:US USD -85093000 14.32M
Bristol Myers Squibb BMY:US USD 4.66B 663M
Coherus Biosciences CHRS:US USD -50443000 29.01M
Endo International Ordinary Shares ENDP:US USD 151.76M 22.28M
Fujifilm 4901:JP JPY 117.73B 10.7B
Gilead Sciences GILD:US USD 2.7B 662M
Horizon Pharma HZNP:US USD 313.74M 26.49M
Ironwood Pharmaceuticals IRWD:US USD 68.7M 133K
JAZZ PHA JAZZ:US USD -118655000 466.69M
Myriad Genetics MYGN:US USD -32300000 400K
Pacira Pharmaceuticals PCRX:US USD 44.76M 2.79M
Perrigo Ordinary Shares PRGO:US USD 138.4M 2.3M
Pfizer PFE:US USD 6.94B 3.94B
Ptc Therapeutics PTCT:US USD -128092000 94.38M
Revance Therapeutics RVNC:US USD -57156000 14.89M
Sarepta Therapeutics SRPT:US USD -96280000 24.37M
Teva Pharmaceutical TEVA:IT USD 1.31B 245M
Xencor XNCR:US USD -40434000 4.32M
Zoetis ZTS:US USD 817M 23M